JP4525221B2 - 受容体リガンド同定法 - Google Patents

受容体リガンド同定法 Download PDF

Info

Publication number
JP4525221B2
JP4525221B2 JP2004210868A JP2004210868A JP4525221B2 JP 4525221 B2 JP4525221 B2 JP 4525221B2 JP 2004210868 A JP2004210868 A JP 2004210868A JP 2004210868 A JP2004210868 A JP 2004210868A JP 4525221 B2 JP4525221 B2 JP 4525221B2
Authority
JP
Japan
Prior art keywords
group
nuclear receptor
substituted
pparγ
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004210868A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006030037A (ja
JP2006030037A5 (https=
Inventor
琢磨 白木
成敏 神谷
久人 陣上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Priority to JP2004210868A priority Critical patent/JP4525221B2/ja
Publication of JP2006030037A publication Critical patent/JP2006030037A/ja
Publication of JP2006030037A5 publication Critical patent/JP2006030037A5/ja
Application granted granted Critical
Publication of JP4525221B2 publication Critical patent/JP4525221B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2004210868A 2004-07-16 2004-07-16 受容体リガンド同定法 Expired - Fee Related JP4525221B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004210868A JP4525221B2 (ja) 2004-07-16 2004-07-16 受容体リガンド同定法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004210868A JP4525221B2 (ja) 2004-07-16 2004-07-16 受容体リガンド同定法

Publications (3)

Publication Number Publication Date
JP2006030037A JP2006030037A (ja) 2006-02-02
JP2006030037A5 JP2006030037A5 (https=) 2007-08-23
JP4525221B2 true JP4525221B2 (ja) 2010-08-18

Family

ID=35896572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004210868A Expired - Fee Related JP4525221B2 (ja) 2004-07-16 2004-07-16 受容体リガンド同定法

Country Status (1)

Country Link
JP (1) JP4525221B2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2181710A1 (en) * 2008-10-28 2010-05-05 Phenex Pharmaceuticals AG Ligands for modulation of orphan receptor-gamma (NR1F3) activity
JP2011037739A (ja) * 2009-08-10 2011-02-24 Pola Chemical Industries Inc 組成物
WO2014026330A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
JP2023047726A (ja) * 2021-09-27 2023-04-06 富士通株式会社 初期構造生成装置、初期構造生成方法及び初期構造生成プログラム
JPWO2024204454A1 (https=) * 2023-03-29 2024-10-03

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002102364A1 (ja) * 2001-06-18 2004-09-30 山田　幸子 ＰＰＡＲγ作動性医薬組成物
US7396642B2 (en) * 2001-07-17 2008-07-08 Teijin Limited Methods of screening for a compound that enhances thermogenesis
GB0119920D0 (en) * 2001-08-15 2001-10-10 Pfizer Ltd New use

Also Published As

Publication number Publication date
JP2006030037A (ja) 2006-02-02

Similar Documents

Publication Publication Date Title
US7778779B2 (en) Method of identifying a chemical entity which is a hydroxylase modulator
JP2003511467A (ja) アンドロゲンレセプターリガンド結合ドメインの結晶構造
Jin et al. Communication between the ligand-binding pocket and the activation function-2 domain of androgen receptor revealed by molecular dynamics simulations
Ogburn et al. Discovery of tamoxifen and N-desmethyl tamoxifen protein targets in MCF-7 cells using large-scale protein folding and stability measurements
Karttunen et al. Prediction of binding energy of Keap1 interaction motifs in the Nrf2 antioxidant pathway and design of potential high-affinity peptides
Bragantini et al. Functional and structural insights of the zinc-finger HIT protein family members involved in box C/D snoRNP biogenesis
Murcia Rios et al. Evidence for a partially stalled γ rotor in F1-ATPase from hydrogen–deuterium exchange experiments and molecular dynamics simulations
Hu et al. Metal binding mediated conformational change of XPA protein: a potential cytotoxic mechanism of nickel in the nucleotide excision repair
Dixon et al. Atomic-resolution prediction of degrader-mediated ternary complex structures by combining molecular simulations with hydrogen deuterium exchange
Han et al. Understanding the phosphorylation mechanism by using quantum chemical calculations and molecular dynamics simulations
JP4525221B2 (ja) 受容体リガンド同定法
Yu et al. The Crystal Structure of Calmodulin Bound to the Cardiac Ryanodine Receptor (RyR2) at Residues Phe4246–Val4271 Reveals a Fifth Calcium Binding Site
Cole et al. Interrogation of the protein-protein interactions between human BRCA2 BRC repeats and RAD51 reveals atomistic determinants of affinity
Yan et al. Understanding the specificity of a docking interaction between JNK1 and the scaffolding protein JIP1
Kim et al. Visualizing heterogeneous protein conformations with multi-tilt nanoparticle-aided cryo-electron microscopy sampling
Lwin et al. A fluid salt-bridging cluster and the stabilization of p53
Ma et al. Inhibition of CYP2C8 by metallofullerenol Gd@ C82 (OH) 22 through blocking substrate channels and substrate recognition sites
WO2011033322A2 (en) Crystal structure
Cardone et al. Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP
US9483609B2 (en) Pharmacogenic therapies targeting the metal-ion transcriptional regulation machinery in bacteria
US8455244B2 (en) Co-crystallization of ERR-α with a ligand that forms a reversible covalent bond
Yadav et al. Cryo-EM Structure-guided Selection of Computed Ligand Poses to Enhance Potency in MTA-synergic Inhibition of Human Protein Arginine Methyltransferase 5
JPWO2005054460A1 (ja) 酸化ｌｄｌ受容体ｌｏｘ−１の酸化ｌｄｌ認識ドメインの結晶およびその立体構造ならびにその利用
Pastore et al. Insights in Structural Biology: 2021
Noji et al. Computational investigation of the substrate recognition mechanism of protein d-aspartyl (l-isoaspartyl) O-methyltransferase by docking and molecular dynamics simulation studies and application to interpret size exclusion chromatography data

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060221

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20070510

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20070514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070629

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070629

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090917

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100413

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100416

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100511

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100524

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees